|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0079083,
umls-concept:C0205263,
umls-concept:C0205420,
umls-concept:C0246415,
umls-concept:C0332174,
umls-concept:C0332283,
umls-concept:C0441771,
umls-concept:C0543467,
umls-concept:C0920321,
umls-concept:C1522449
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-5-9
|
|
pubmed:abstractText |
To determine the maximum-tolerated dose of docetaxel (DOC) in combination with carboplatin (CAR) and thoracic radiotherapy (RT), in the setting of trimodality treatment of patients with stage III non-small cell lung cancer (NSCLC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BermanStuart MSM,
pubmed-author:ChoiNoah CNC,
pubmed-author:FidiasPanosP,
pubmed-author:HerbstRoy SRS,
pubmed-author:JännePasi APA,
pubmed-author:JohnsonBruce EBE,
pubmed-author:LuccaJoanJ,
pubmed-author:LukanichJeanne MJM,
pubmed-author:LynchCathyC,
pubmed-author:MathisenDouglas JDJ,
pubmed-author:OstlerPatriciaP,
pubmed-author:SkarinArthur TAT,
pubmed-author:SugarbakerDavid JDJ,
pubmed-author:WirthLori JLJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1698-704
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12738723-Aged,
pubmed-meshheading:12738723-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12738723-Carboplatin,
pubmed-meshheading:12738723-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12738723-Combined Modality Therapy,
pubmed-meshheading:12738723-Dose-Response Relationship, Drug,
pubmed-meshheading:12738723-Female,
pubmed-meshheading:12738723-Humans,
pubmed-meshheading:12738723-Lung Neoplasms,
pubmed-meshheading:12738723-Male,
pubmed-meshheading:12738723-Maximum Tolerated Dose,
pubmed-meshheading:12738723-Middle Aged,
pubmed-meshheading:12738723-Neoplasm Staging,
pubmed-meshheading:12738723-Remission Induction,
pubmed-meshheading:12738723-Taxoids,
pubmed-meshheading:12738723-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.
|
|
pubmed:affiliation |
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
